Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling.

Drug discovery today·2016

Same author

A tunable hydrogel system for long-term release of cell-secreted cytokines and bioprinted in situ wound cell delivery.

Journal of biomedical materials research. Part B, Applied biomaterials·2016

Same author

Re: A Tumor Mitochondria Vaccine Protects against Experimental Renal Cell Carcinoma.

The Journal of urology·2016

Same author

Re: Endogenous Formaldehyde is a Hematopoietic Stem Cell Genotoxin and Metabolic Carcinogen.

The Journal of urology·2016

Same author

Re: Sphaeropsidin A Shows Promising Activity against Drug-Resistant Cancer Cells by Targeting Regulatory Volume Increase.

The Journal of urology·2016

Same author

Re: Sex Hormone-Dependent tRNA Halves Enhance Cell Proliferation in Breast and Prostate Cancers.

The Journal of urology·2016

Search research articles

Related Experiment Video

Updated: Apr 18, 2026

Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids

Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids

Published on: August 11, 2017

Manufacturing road map for tissue engineering and regenerative medicine technologies.

Joshua Hunsberger¹, Ola Harrysson², Rohan Shirwaiker²

¹Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA;

Stem Cells Translational Medicine

|January 11, 2015

Summary

Leaders convened to discuss translating tissue engineering and regenerative medicine (TERM) technologies to the clinic. Advanced manufacturing solutions and a roadmap for TERM infrastructure were identified to overcome translation and scale-up challenges.

More Related Videos

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets

Published on: October 3, 2014

Core/shell Printing Scaffolds For Tissue Engineering Of Tubular Structures

Core/shell Printing Scaffolds For Tissue Engineering Of Tubular Structures

Published on: September 27, 2019

Related Experiment Videos

Last Updated: Apr 18, 2026

Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids

Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids

Published on: August 11, 2017

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets

Published on: October 3, 2014

Core/shell Printing Scaffolds For Tissue Engineering Of Tubular Structures

Core/shell Printing Scaffolds For Tissue Engineering Of Tubular Structures

Published on: September 27, 2019

Area of Science:

Regenerative Medicine
Tissue Engineering
Biotechnology Manufacturing

Background:

The Regenerative Medicine Foundation Annual Conference (2014) aimed to advance the clinical translation of tissue engineering and regenerative medicine (TERM) technologies.
Key areas discussed included regulatory pathways, industry partnerships, resource coordination, standards development, and government support.

Purpose of the Study:

To identify and address roadblocks in the clinical translation and manufacturing scale-up of regenerative medicine therapies.
To outline a roadmap for developing essential TERM manufacturing infrastructure, resources, standards, and workforce capabilities.

Main Methods:

Focused manufacturing sessions with experts from industry, government, and academia.
Industry survey to further identify challenges in translation and scale-up.
Analysis of lessons learned from conference sessions and survey results.

Main Results:

Advanced manufacturing improvements offer solutions to identified roadblocks in regenerative medicine.
Specific challenges in product development, process scale-up, and infrastructure needs were detailed.
Early survey results provided further insights into translation and scale-up hurdles.

Conclusions:

Developing a comprehensive roadmap is crucial for advancing regenerative medicine manufacturing.
Addressing infrastructure, resources, standards, education, and workforce development is essential to realize the full potential of TERM therapies.